Carregant...
Tumor-specific Immunotherapy Targeting the EGFRvIII Mutation in Patients with Malignant Glioma
Conventional therapies for malignant gliomas (MGs) fail to target tumor cells exclusively, such that their efficacy is ultimately limited by non-specific toxicity. Immunologic targeting of tumor-specific gene mutations, however, may allow more precise eradication of neoplastic cells. The epidermal g...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2633865/ https://ncbi.nlm.nih.gov/pubmed/18539480 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.smim.2008.04.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|